Cyclooxygenase-2 mediated regulation of E-cadherin occurs in conventional but not early-onset gastric cancer cell lines

Cellular Oncology

Volumn 31, Issue 6, 2009, Pages 475-485

  Sitarz, R ^a,b   Leguit, R J ^a   De Leng, W W J ^a   Morsink, F H M ^a   Polkowski, W P ^b   Maciejewski, R ^b   Offerhaus, G J A ^a,c   Milne, A N ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

CDH1 mutation; Celecoxib; COX 2; E cadherin; Early onset gastric cancer

Indexed keywords

CELECOXIB; CYCLOOXYGENASE 2; UVOMORULIN;

ADULT; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; GENE MUTATION; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; STOMACH CANCER; UPREGULATION; WESTERN BLOTTING;

ADULT; AGE OF ONSET; BLOTTING, WESTERN; CADHERINS; CELL LINE, TUMOR; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; DINOPROSTONE; DNA MUTATIONAL ANALYSIS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; MUTATION; NETHERLANDS; PYRAZOLES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STOMACH NEOPLASMS; SULFONAMIDES; TISSUE ARRAY ANALYSIS;

EID: 71949098416     PISSN: 15705870     EISSN: None     Source Type: Journal    
DOI: 10.3233/CLO-2009-0496     Document Type: Article

References (42)

1. K.F. Becker, M.J. Atkinson, U. Reich, I. Becker, H. Nekarda, J.R. Siewert and H. Hofler, E-cadherin gene mutations provide clues to diffuse type gastric carcinomas, Cancer Res. 54 (1994), 3845-3852.
2. G. Berx, A.M. Cleton-Jansen, F. Nollet,W.J. de Leeuw, M. van de Vijver, C. Cornelisse and F. van Roy, E-cadherin is a tumour/invasion suppressor gene mutated in human lobular breast cancers, EMBO J. 14 (1995), 6107-6115.
3. M.J. Blanco, G. Moreno-Bueno, D. Sarrio, A. Locascio, A. Cano, J. Palacios and M.A. Nieto, Correlation of Snail expression with histological grade and lymph node status in breast carcinomas, Oncogene 21 (2002), 3241-3246.
4. F. Bray, R. Sankila, J. Ferlay and D.M. Parkin, Estimates of cancer incidence and mortality in Europe in 1995, Eur. J. Cancer 38 (2002), 99-166.
5. C.J. Buskens, B.P. Van Rees, A. Sivula, J.B. Reitsma, C. Haglund, P.J. Bosma, G.J. Offerhaus, J.J. Van Lanschot and A. Ristimaki, Prognostic significance of elevated cyclooxygenase 2 expression in patients with adenocarcinoma of the esophagus, Gastroenterology 122 (2002), 1800-1807. (Pubitemid 34651424)
6. A. Cano, M.A. Perez-Moreno, I. Rodrigo, A. Locascio, M.J. Blanco, M.G. del Barrio, F. Portillo and M.A. Nieto, The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression, Nat. Cell Biol. 2 (2000), 76-83. (Pubitemid 30785917)
7. R. Carvalho, A.N. Milne, M. Polak, W.E. Corver, G.J. Offerhaus and M.A. Weterman, Exclusion of RUNX3 as a tumour-suppressor gene in early-onset gastric carcinomas, Oncogene 24 (2005), 8252-8258.
8. R. Carvalho, A.N. Milne, B.P. van Rees, E. Caspers, L. Cirnes, C. Figueiredo, G.J. Offerhaus andM.A.Weterman, Early-onset gastric carcinomas display molecular characteristics distinct from gastric carcinomas occurring at a later age, J. Pathol. 204 (2004), 75-83.
9. C. Come, F. Magnino, F. Bibeau, P. De Santa Barbara, K.F. Becker, C. Theillet and P. Savagner, Snail and slug play distinct roles during breast carcinoma progression, Clin. Cancer Res. 12 (2006), 5395-5402.
10. P. Correa and Y.H. Shiao, Phenotypic and genotypic events in gastric carcinogenesis, Cancer Res. 54 (1994), 1941S-1943S.
11. M. Dohadwala, S.C. Yang, J. Luo, S. Sharma, R.K. Batra, M. Huang, Y. Lin, L. Goodglick, K. Krysan, M.C. Fishbein, L. Hong, C. Lai, R.B. Cameron, R.M. Gemmill, H.A. Drabkin and S.M. Dubinett, Cyclooxygenase-2-dependent regulation of E-cadherin: prostaglandin E(2) induces transcriptional repressors ZEB1 and snail in non-small cell lung cancer, Cancer Res. 66 (2006), 5338-5345.
12. S. Elloul, M.B. Elstrand, J.M. Nesland, C.G. Trope, G. Kvalheim, I. Goldberg, R. Reich and B. Davidson, Snail, slug, and smad-interacting protein 1 as novel parameters of disease aggressiveness in metastatic ovarian and breast carcinoma, Cancer 103 (2005), 1631-1643.
13. G. Gridley, J.K. McLaughlin, A. Ekbom, L. Klareskog, H.O. Adami, D.G. Hacker, R. Hoover and J.F. Fraumeni Jr., Incidence of cancer among patients with rheumatoid arthritis, J. Natl. Cancer Inst. 85 (1993), 307-311. (Pubitemid 23068804)
14. D.G. Huntsman, F. Carneiro, F.R. Lewis, P.M. MacLeod, A. Hayashi, K.G. Monaghan, R. Maung, R. Seruca, C.E. Jackson and C. Caldas, Early gastric cancer in young, asymptomatic carriers of germ-line E-cadherin mutations, N. Engl. J. Med. 344 (2001), 1904-1909.
15. P.A. Konstantinopoulos, G.P. Vandoros, M.V. Karamouzis, M. Gkermpesi, G. Sotiropoulou-Bonikou and A.G. Papavassiliou, EGF-R is expressed and AP-1 and NF-kappaB are activated in stromal myofibroblasts surrounding colon adenocarcinomas paralleling expression of COX-2 and VEGF, Cell. Oncol. 29 (2007), 477-482.
16. P. Lauren, The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification, Acta Pathol. Microbiol. Scand. 64 (1965), 31-49.
17. A. Locascio, S. Vega, C.A. de Frutos,M. Manzanares andM.A. Nieto, Biological potential of a functional human SNAIL retrogene, J. Biol. Chem. 277 (2002), 38803-38809.
18. A. Lochter, S. Galosy, J. Muschler, N. Freedman, Z. Werb and M.J. Bissell, Matrix metalloproteinase stromelysin-1 triggers a cascade of molecular alterations that leads to stable epithelialtomesenchymal conversion and a premalignant phenotype in mammary epithelial cells, J. Cell. Biol. 139 (1997), 1861-1872.
19. J.C. Machado, C. Oliveira, R. Carvalho, P. Soares, G. Berx, C. Caldas, R. Seruca, F. Carneiro and M. Sobrinho-Simoes, E-cadherin gene (CDH1) promoter methylation as the second hit in sporadic diffuse gastric carcinoma, Oncogene 20 (2001), 1525-1528.
20. A.N. Milne, R. Carvalho, F.M. Morsink, A.R. Musler, W.W. de Leng, A. Ristimaki and G.J. Offerhaus, Early-onset gastric cancers have a different molecular expression profile than conventional gastric cancers, Mod. Pathol. 19 (2006), 564-572.
21. A.N. Milne, R. Sitarz, R. Carvalho, F. Carneiro and G.J. Offerhaus, Early onset gastric cancer: on the road to unraveling gastric carcinogenesis, Curr. Mol. Med. 7 (2007), 15-28.
22. A.N. Milne, R. Sitarz, R. Carvalho, M.M. Polak, M. Ligtenberg, P. Pauwels, G.J. Offerhaus and M.A. Weterman, Molecular analysis of primary gastric cancer, corresponding xenografts, and 2 novel gastric carcinoma cell lines reveals novel alterations in gastric carcinogenesis, Hum. Pathol. 38 (2007), 903-913.
23. Mingchao, T.R. Devereux, P. Stockton, K. Sun, R.C. Sills, N. Clayton, M. Portier and G. Flake, Loss of E-cadherin expression in gastric intestinal metaplasia and later stage p53 altered expression in gastric carcinogenesis, Exp. Toxicol. Pathol. 53 (2001), 237-246.
24. K. Nithipatikom, M.A. Isbell, P.F. Lindholm, A. Kajdacsy-Balla, S. Kaul and W.B. Campell, Requirement of cyclooxygenase- 2 expression and prostaglandins for human prostate cancer cell invasion, Clin. Exp. Metastasis 19 (2002), 593-601.
25. M. Noda, Y. Tatsumi, M. Tomizawa, T. Takama, S. Mitsufuji, H. Sugihara, K. Kashima and T. Hattori, Effects of etodolac, a selective cyclooxygenase-2 inhibitor, on the expression of E-cadherin-catenin complexes in gastrointestinal cell lines, J. Gastroenterol. 37 (2002), 896-904.
26. T. Oda, Y. Kanai, T. Oyama, K. Yoshiura, Y. Shimoyama, W. Birchmeier, T. Sugimura and S. Hirohashi, E-cadherin gene mutations in human gastric carcinoma cell lines, Proc. Natl. Acad. Sci. USA 91 (1994), 1858-1862. (Pubitemid 24080305)
27. D.M. Parkin, F. Bray, J. Ferlay and P. Pisani, Global cancer statistics, 2002, CA Cancer J. Clin. 55 (2005), 74-108.
28. H. Peinado, D. Olmeda and A. Cano, Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?, Nat. Rev. Cancer 7 (2007), 415-428.
29. R.K. Phillips, M.H. Wallace, P.M. Lynch, E. Hawk, G.B. Gordon, B.P. Saunders, N. Wakabayashi, Y. Shen, S. Zimmerman, L. Godio, M. Rodrigues-Bigas, L.K. Su, J. Sherman, G. Kelloff, B. Levin and G. Steinbach, A randomised, double blind, placebo controlled study of celecoxib, a selective cyclooxygenase 2 inhibitor, on duodenal polyposis in familial adenomatous polyposis, Gut 50 (2002), 857-860.
30. D.S. Rao, D. Gui, M.E. Koski, L.M. Popoviciu, H. Wang, R.E. Reiter and J.W. Said, An inverse relation between COX-2 and E-cadherin expression correlates with aggressive histologic features in prostate cancer, Appl. Immunohistochem. Mol. Morphol. 14 (2006), 375-383.
31. M.G. Rashid, M.G. Sanda, C.J. Vallorosi, J. Rios-Doria, M.A. Rubin and M.L. Day, Posttranslational truncation and inactivation of human E-cadherin distinguishes prostate cancer from matched normal prostate, Cancer Res. 61 (2001), 489-492.
32. K.L. Reckamp, B.K. Gardner, R.A. Figlin, D. Elashoff, K. Krysan, M. Dohadwala, J. Mao, S. Sharma, L. Inge, A. Rajasekaran and S.M. Dubinett, Tumor response to combination celecoxib and erlotinib therapy in non-small cell lung cancer is associated with a low baseline matrix metalloproteinase-9 and a decline in serum-soluble E-cadherin, J. Thorac Oncol. 3 (2008), 117-124.
33. A. Ristimaki, N. Honkanen, H. Jankala, P. Sipponen and M. Harkonen, Expression of cyclooxygenase-2 in human gastric carcinoma, Cancer Res. 57 (1997), 1276-1280. (Pubitemid 27152551)
34. E. Rosivatz, I. Becker, K. Specht, E. Fricke, B. Luber, R. Busch, H. Hofler and K.F. Becker, Differential expression of the epithelial-mesenchymal transition regulators snail, SIP1, and twist in gastric cancer, Am. J. Pathol. 161 (2002), 1881-1891.
35. K. Saukkonen, O. Nieminen, B. van Rees, S. Vilkki,M. Harkonen, M. Juhola, J.P. Mecklin, P. Sipponen and A. Ristimaki, Expression of cyclooxygenase-2 in dysplasia of the stomach and in intestinal-type gastric adenocarcinoma, Clin. Cancer Res. 7 (2001), 1923-1931.
36. K. Saukkonen, J. Rintahaka, A. Sivula, C.J. Buskens, B.P. Van Rees, M.C. Rio, C. Haglund, J.J. Van Lanschot, G.J. Offerhaus and A. Ristimaki, Cyclooxygenase-2 and gastric carcinogenesis, APMIS 111 (2003), 915-925.
37. R.F. Souza, K. Shewmake, D.G. Beer, B. Cryer and S.J. Spechler, Selective inhibition of cyclooxygenase-2 suppresses growth and induces apoptosis in human esophageal adenocarcinoma cells, Cancer Res. 60 (2000), 5767-5772. (Pubitemid 30808313)
38. G. Steinbach, P.M. Lynch, R.K. Phillips, M.H. Wallace, E. Hawk, G.B. Gordon, N.Wakabayashi, B. Saunders, Y. Shen, T. Fujimura, L.K. Su and B. Levin, The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis, N. Engl. J. Med. 342 (2000), 1946-1952.
39. M. Tsujii, S. Kawano, S. Tsuji, H. Sawaoka, M. Hori and R.N. DuBois, Cyclooxygenase regulates angiogenesis induced by colon cancer cells, Cell 93 (1998), 705-716.
40. B.P. van Rees, K. Saukkonen, A. Ristimaki, W. Polkowski, G.N. Tytgat, P. Drillenburg and G.J. Offerhaus, Cyclooxygenase- 2 expression during carcinogenesis in the human stomach, J. Pathol. 196 (2002), 171-179. (Pubitemid 34110898)
41. B.P. Wijnhoven, W.N. Dinjens and M. Pignatelli, E-cadherincatenin cell-cell adhesion complex and human cancer, Br. J. Surg. 87 (2000), 992-1005. (Pubitemid 30496847)
42. M. Yamagishi, M. Noda, Y. Tatsumi, K. Mukaisho, S. Mitsufuji, H. Sugihara, T. Okanoue and T. Hattori, Correlation between cyclooxygenase-2, proliferative activity, and mucin phenotype in human advanced gastric cancer, J. Gastroenterol. 39 (2004), 1143-1149.